Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 2/2007

01.02.2007

Gastric Adenocarcinoma: Reduction of Perioperative Mortality by Avoidance of Nontherapeutic Laparotomy

verfasst von: Brian R. Smith, Bruce E. Stabile

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

National trends indicate a longstanding decline in gastric adenocarcinoma due presumably to a decreasing prevalence of Helicobacter pylori infection. Nonetheless, surgical outcomes continue to include relatively high morbidity and mortality rates owing to the advanced stage of disease encountered. We hypothesize that recent immigration patterns are responsible for a leveling off or even reversal of the declining incidence of gastric cancer associated with H. pylori infection. Furthermore, advances in preoperative tumor staging and nonoperative palliation currently permit better patient selection for operation with lower perioperative morbidity and mortality. A retrospective review of a consecutive case series at a public teaching hospital located in an area of high immigration was conducted that included all patients presenting, from 1995 through 2004, with gastric adenocarcinoma. For time comparison purposes, patients were divided into early (1995–1999) and recent (2000–2004) periods. There was no decline in the frequency of gastric adenocarcinoma among the study population over the 10 years. A total of 260 patients were treated of whom 137 (53%) underwent operation. The operation rate decreased and the gastric resection rate increased from the early period to the recent period as fewer incurable advanced stage (M1) patients underwent exploratory laparotomy and were palliated by nonoperative means. Perioperative morbidity and mortality rates also declined over time. Of the four total perioperative deaths, two followed 11 nontherapeutic laparotomies (18% mortality), whereas the only two additional deaths followed 122 curative or palliative laparotomies (2% mortality) (p = 0.034). We conclude that in an area of high immigration there has been no decline in gastric adenocarcinoma rates over the past decade, and the marked reduction in perioperative mortality was due to near elimination of nontherapeutic laparotomy.
Literatur
1.
Zurück zum Zitat Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1–27.PubMed Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1–27.PubMed
2.
Zurück zum Zitat Sipponen P. Helicobacter pylori infection—a common worldwide environmental risk factor for gastric cancer? Endoscopy 1992;24:424–427.PubMedCrossRef Sipponen P. Helicobacter pylori infection—a common worldwide environmental risk factor for gastric cancer? Endoscopy 1992;24:424–427.PubMedCrossRef
3.
Zurück zum Zitat Sipponen P. Helicobacter pylori: A cohort phenomenon. Am J Surg Pathol 1995;19(Suppl 1):S30–S36.PubMed Sipponen P. Helicobacter pylori: A cohort phenomenon. Am J Surg Pathol 1995;19(Suppl 1):S30–S36.PubMed
4.
Zurück zum Zitat Imrie C, Rowland M, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373–380.PubMedCrossRef Imrie C, Rowland M, Bourke B, Drumm B. Is Helicobacter pylori infection in childhood a risk factor for gastric cancer? Pediatrics 2001;107:373–380.PubMedCrossRef
5.
Zurück zum Zitat Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169–1179.PubMedCrossRef Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169–1179.PubMedCrossRef
6.
Zurück zum Zitat Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—Part II. Curr Probl Surg 2005;42:791–862. Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—Part II. Curr Probl Surg 2005;42:791–862.
7.
Zurück zum Zitat Siewert JR, Böttcher K, Stein H, Roder JD. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–461.PubMedCrossRef Siewert JR, Böttcher K, Stein H, Roder JD. Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–461.PubMedCrossRef
8.
Zurück zum Zitat Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–789.PubMedCrossRef Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–789.PubMedCrossRef
10.
Zurück zum Zitat Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—Part I. Curr Probl Surg 2005;42:743–790. Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—Part I. Curr Probl Surg 2005;42:743–790.
11.
Zurück zum Zitat Smith BR, Stabile BE. Emerging trends in peptic ulcer disease and damage control surgery in the H. pylori era. The American Surgeon 2005;71:797–801. Smith BR, Stabile BE. Emerging trends in peptic ulcer disease and damage control surgery in the H. pylori era. The American Surgeon 2005;71:797–801.
12.
Zurück zum Zitat Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol 2005;25:6220–6232.CrossRef Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol 2005;25:6220–6232.CrossRef
13.
Zurück zum Zitat Lee YT, Ng EKW, Hung LCT, Chung SCS, Ching JYL, Chan WY, et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut 2005;54:1541–1545.PubMedCrossRef Lee YT, Ng EKW, Hung LCT, Chung SCS, Ching JYL, Chan WY, et al. Accuracy of endoscopic ultrasonography in diagnosing ascites and predicting peritoneal metastases in gastric cancer patients. Gut 2005;54:1541–1545.PubMedCrossRef
14.
Zurück zum Zitat Conlon KC, Karpeh MS Jr. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol 1996;23:347–351.PubMed Conlon KC, Karpeh MS Jr. Laparoscopy and laparoscopic ultrasound in the staging of gastric cancer. Semin Oncol 1996;23:347–351.PubMed
15.
Zurück zum Zitat Asencio F, Aguilo J, Salvador JL, Villar A, De la Morena E, Ahamad M, et al. Video-laparoscopic staging of gastric cancer: A prospective multicenter comparison with noninvasive techniques. Surg Endosc 1997;11:1153–1158.PubMedCrossRef Asencio F, Aguilo J, Salvador JL, Villar A, De la Morena E, Ahamad M, et al. Video-laparoscopic staging of gastric cancer: A prospective multicenter comparison with noninvasive techniques. Surg Endosc 1997;11:1153–1158.PubMedCrossRef
16.
Zurück zum Zitat Jansen EPM, Boot H, Verheij M, van de Velde CJH. Optimal locoregional treatment in gastric cancer. J Clin Oncol 2005;23:4509–4517.PubMedCrossRef Jansen EPM, Boot H, Verheij M, van de Velde CJH. Optimal locoregional treatment in gastric cancer. J Clin Oncol 2005;23:4509–4517.PubMedCrossRef
17.
Zurück zum Zitat Valen B, Viste A, Haugstvedt T, Elide GE, Soreido O. Treatment of stomach cancer, a national experience. Br J Surg 1988;75:708–712.PubMedCrossRef Valen B, Viste A, Haugstvedt T, Elide GE, Soreido O. Treatment of stomach cancer, a national experience. Br J Surg 1988;75:708–712.PubMedCrossRef
18.
Zurück zum Zitat Viste A, Haugstvedt T, Eide E, Soreide O. Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988;207:7–213.PubMedCrossRef Viste A, Haugstvedt T, Eide E, Soreide O. Postoperative complications and mortality after surgery for gastric cancer. Ann Surg 1988;207:7–213.PubMedCrossRef
19.
Zurück zum Zitat Tsioulias GJ, Wood TF, Chung MH, Morton DL, Bilchik A. Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and respectability of intraabdominal neoplasms. Surg Endosc 2001;15:1016–1019.PubMedCrossRef Tsioulias GJ, Wood TF, Chung MH, Morton DL, Bilchik A. Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and respectability of intraabdominal neoplasms. Surg Endosc 2001;15:1016–1019.PubMedCrossRef
20.
Zurück zum Zitat Pollack BJ, Chak A, Sivak MV Jr. Endoscopic ultrasonography. Semin Oncol 1996;23:336–346.PubMed Pollack BJ, Chak A, Sivak MV Jr. Endoscopic ultrasonography. Semin Oncol 1996;23:336–346.PubMed
21.
Zurück zum Zitat Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993;113:14–27.PubMed Caletti G, Ferrari A, Brocchi E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993;113:14–27.PubMed
22.
Zurück zum Zitat Chang KJ, Katz KD, Durbin TE, Erickson RA, Bulter JA, Lin F, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc 1994;40:694–699.PubMed Chang KJ, Katz KD, Durbin TE, Erickson RA, Bulter JA, Lin F, et al. Endoscopic ultrasound-guided fine-needle aspiration. Gastrointest Endosc 1994;40:694–699.PubMed
23.
Zurück zum Zitat Stell DA, Carter CR, Steward I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996;83:1260–1262.PubMedCrossRef Stell DA, Carter CR, Steward I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996;83:1260–1262.PubMedCrossRef
Metadaten
Titel
Gastric Adenocarcinoma: Reduction of Perioperative Mortality by Avoidance of Nontherapeutic Laparotomy
verfasst von
Brian R. Smith
Bruce E. Stabile
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2007
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-006-0019-5

Weitere Artikel der Ausgabe 2/2007

Journal of Gastrointestinal Surgery 2/2007 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.